ABOUT THE PACKARD CENTER

Packard Center for ALS Research at Johns Hopkins

  • 90

    EVERY 90 MINUTES A PERSON IN THE U.S. IS DIAGNOSED

ALS Headlines

ALS Headlines from the Packard Center
  1. 3-D Hand Movement Reconstructed Using Brain Signals

    Researchers have successfully reconstructed 3-D hand motions from brain signals recorded in a non-invasive way. This finding uses a technique that may open new doors for portable brain-computer interface systems.
    Tue, 09 Mar 2010 03:43:22 GMThttp://www.alscenter.org/news/rss_als_headlines/10_03_08.html
  2. Induced Neural Stem Cells: Not Quite Ready for Prime Time

    The great promise of induced pluripotent stem cells is that the all-purpose cells seem capable of performing all the same tricks as embryonic stem cells, but without the controversy.
    Thu, 18 Feb 2010 19:24:16 GMThttp://www.alscenter.org/news/rss_als_headlines/10_02_16
  3. New Class of Brain-Protecting Drugs Emerging

    Researchers have identified a compound that mimics one of the brain's own growth factors and can protect brain cells against damage in several animal models of neurological disease.
    Tue, 02 Feb 2010 18:03:25 GMThttp://www.alscenter.org/news/rss_als_headlines/10_02_02.html
  4. First U.S. stem cells transplanted into spinal cord

    Doctors injected stem cells from 8-week-old fetal tissue into the spine of a man in his early 60s who has advanced ALS, or amyotrophic lateral sclerosis.
    Fri, 22 Jan 2010 20:37:47 GMThttp://www.alscenter.org/news/rss_als_headlines/10_01_21_cnn.html
  5. Role of Key Protein in ALS and Frontotemporal Dementia Identified

    Scientists at the Gladstone Institute of Neurological Disease (GIND) have identified the reason a key protein plays a major role in two neurodegenerative diseases.
    Thu, 21 Jan 2010 04:20:33 GMThttp://www.alscenter.org/news/rss_als_headlines/10_10_15_sd.html

From The Center

News from the Robert Packard Center for ALS Research at Johns Hopkins
  1. License Agreement to Develop New Treatments for Neurological Disease

    Newly formed NeuroTranslational Program at JHU has entered into a licensing agreement with pharmaceutical company Eisai Inc. to discover and develop small molecule glutamate carboxypeptidase II (GCPII) inhibitors.
    Mon, 15 Mar 2010 17:38:45 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/10_03_15.html
  2. NIH Grant Funds Study on Stem Cells from ALS Patients

    A two-year $3.7 million stimulus grant from the National Institutes of Health will allow Johns Hopkins neurologist Jeffrey Rothstein to expand on his research into the nerve- and muscle-wasting disease amyotrophic lateral sclerosis, or ALS.
    Tue, 23 Feb 2010 18:32:33 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/10_02_22.html
  3. Project A.L.S. and Packard Center Take Aim at ALS with $15 Million Program

    Project A.L.S. and the Robert Packard Center for ALS Research at Johns Hopkins will partner on P2 ALS, a $15 million initiative designed to advance ALS research exponentially over the next three years.
    Fri, 29 Jan 2010 15:03:47 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_29.html
  4. Why the New Antisense Trials Make Sense for ALS

    This February, a new entry in the ALS clinical trials system will have top scientists watching intently for results. It’s the start of human tests of a therapy based on a totally new principle—one that works by silencing mutant genes.
    Thu, 28 Jan 2010 16:54:15 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_28.html
  5. Stem Cells Can Form Correct Motor Connections in the Brain

    New animal study shows neurons developed from stem cells successfully wired with other brain regions, including those tied to movement.
    Wed, 20 Jan 2010 14:54:48 GMThttp://www.alscenter.org/news/research_news_archive/10/10_01_19.html
  6. Zumbathon

    Experience up to 3 hours of Zumba for only $10 at Interactive Fitness in Timonium. Saturday, January 23, 2010, 9am-12pm
    Wed, 30 Dec 2009 02:33:58 GMThttp://www.alscenter.org/get_involved/events/event_syndication/10_01_23.html
  7. New Blood Test for ALS Damage Should Tighten Animal Trials

    Right now, there's no quick, reliable way to tell if something has stopped or slowed ALS down. Packard expertise helps bring an easily measured biomarker closer.
    Sun, 27 Dec 2009 02:47:41 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/09_12_15.html
  8. New ALS Drug Still In The Pipeline After Phase II Trial

    A drug already used to treat symptoms of epilepsy has potential to slow the muscle weakening that comes with amyotrophic lateral sclerosis (ALS).
    Sun, 27 Dec 2009 02:41:00 GMThttp://www.alscenter.org/news/rss_from_the_packard_center/09_12_22.html

Events

Johns Hopkins School of Medicine

Contact The Packard Center

© 2010, The Robert Packard Center for ALS Research at Johns Hopkins. All rights reserved.

5801 Smith Avenue, McAuley Suite 110,
Baltimore, Maryland 21209, USA